NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/01/2022
Back to search
Official data from USPTO
RECO2VERY THERAPIES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
RECO2VERY THERAPIES
ST13
US500000090478078Class
5, 10, 44
Filing
90478078
Registration
6887001
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
24
Latest update
11/01/2022
Trademark type
Word
Nice classes
5, 10, 44
Filing date
01/20/2021
Registration date
11/01/2022
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/01/2022
Last transaction
11/01/2022
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
Drawing code
4
Owner type
99
Owner location
Bad Klosterlausnitz, DE
Examiner
LOVELACE, JAMES B
Law office
N10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
ReCO2lung GmbH
Representatives
Margaret C. McHugh KILPATRICK TOWNSEND & STOCKTON LLP
Technical classification
Nice Classes
Class 5Class 10Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Pharmaceuticals and veterinary preparations for the treatment of cardiovascular diseasesheart and circulatory diseasesheart failurecoronary diseasesendovascular diseasesstructural heart diseases
Class 10
Surgicalmedicalveterinary apparatus and instrumentssurgical or medical devices for treating structural heart diseasessurgical or medical devices for treating heart failuresurgical or medical devices for providing endovascular therapyheart and lung assist devicescathetersstents such as coated stents or self-expanding stentsobliteration devicesocclusion devicesimplantable ventricular devicescannulas; Suture materials; Cathetersin particular balloon catheters; Medical apparatus and instruments for treating structural heart disease; Medical devices to treat heart failure; Medical devices for endovascular therapy; Heart and lung support devicesstentslung ventilatorsimplantable ventricular assist devices such as implantable left or right ventricular assist devicespermanent implantable ventricular assist devices; Stents in particular coated stents or self-expanding stents; Obliteration devicesleft atrial appendage (LAA) obliteration devicessurgical devices that facilitate the identificationseparation or ablation of biologic tissues; Occlusion devicescathetersstentspatent foramen ovale (PFO) occlusion devices; atrial septal defect (ASD) occlusion devices; ventricular septal defect (VSD) occlusion devices; Implantable ventricular devicesintravascular implants comprised of artificial material or implantable ventricular assist devices; Cannulae
Class 44
Medical services
Publications
History of USPTO decisions and trademark events.
24 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/01/2022
DP1B
1(B) BASIS DELETED; PROCEED TO REGISTRATION
09/27/2022
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
09/27/2022
IUCN
NOTICE OF ALLOWANCE CANCELLED
09/12/2022
D1BR
TEAS DELETE 1(B) BASIS RECEIVED
09/12/2022
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
06/07/2022
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
04/12/2022
PUBO
PUBLISHED FOR OPPOSITION
04/12/2022
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/23/2022
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
03/10/2022
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
03/09/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/08/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/07/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/07/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/09/2021
GNRT
NON-FINAL ACTION E-MAILED
08/09/2021
CNRT
NON-FINAL ACTION WRITTEN
08/09/2021
DOCK
ASSIGNED TO EXAMINER
08/02/2021
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
05/21/2021
ALIE
ASSIGNED TO LIE
05/21/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/22/2021
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
02/17/2021
NWAP
NEW APPLICATION ENTERED
01/23/2021
Continuous trademark protection
Get notified about every new filing that threatens RECO2VERY THERAPIES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.